SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences (GLSI) is trending as recent FDA approval for commercial manufacturing of its GP2 vaccine in the FLAMINGO-01 trial, combined with stellar Phase 2 open-label data, significantly de-risks its path toward a Biologics License Application (BLA) submission. The community exhibits high conviction, citing CEO Snehal Patel's consistent insider buying and the stock's extremely tight float, which, coupled with high short interest and borrowing costs, fuels intense speculation about a potential short squeeze and significant future valuation in the HER2+ breast cancer market.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending following news of a Neutron rocket tank rupture during qualification testing, which the community is actively dissecting. Many view this as a standard development step to ensure safety margins for its highly anticipated medium-lift rocket, while others express concern over potential delays, all amidst ongoing Electron launch preparations and growing defense contract momentum.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending due to significant U.S. government attention on deep-sea mining, fueled by NOAA's recent actions to streamline permit processes and an upcoming Congressional hearing featuring the company's CEO. This regulatory momentum, coupled with White House recognition of critical deep-sea minerals as a national security priority, is driving strong bullish sentiment and calls for holding amidst high short interest, with investors anticipating expedited commercial recovery.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd

SU Group Holdings Ltd (SUGP) is trending due to intense community discussion centered on its ultra-low share float and significant short interest, leading to strong speculation about a potential short squeeze. Traders are keenly drawing comparisons to past high-volatility runners within the "Hong Kong low float" theme, with sentiment further fueled by a high cost to borrow and anticipation of upcoming earnings or contract news as potential catalysts for a substantial price movement. The company's recent fiscal year financial results reporting revenue growth in security-related engineering services also contribute to the bullish sentiment among market participants.

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.

PAVmed Inc

PAVmed is trending following news that its subsidiary, Lucid Diagnostics, secured a significant U.S. Department of Veterans Affairs contract for its EsoGuard esophageal DNA test, expanding access for millions of veterans. This development, coupled with its notably low share float, is fueling intense speculation within the community about a potential short squeeze and significant upside. While some anticipate sustained momentum with high price targets, others are wary of possible dilution following the sharp rise.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is surging due to recent positive five-year follow-up data from its personalized cancer vaccine trial with Merck, demonstrating a significant reduction in melanoma recurrence risk. This breakthrough is driving community discussions about the transformative potential of mRNA technology in oncology and its broader pipeline, with many reassessing the company's long-term valuation.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is experiencing significant momentum driven by a clearer FDA path for ANKTIVA in bladder cancer and its groundbreaking approval for lung cancer in Saudi Arabia. The community is intensely focused on the drug's potential as a cancer cure and is anticipating a massive short squeeze, fueled by soaring borrow rates and substantial losses for short sellers.

SuperVerse is a unified Web3 ecosystem connecting gaming, DeFi, and AI under a single interoperable protocol. Its native token, $SUPER, powers transactions, governance, and access to immersive games, AI-powered tools, and liquidity infrastructure such as Blackhole DEX. Designed for real utility across multiple chains, $SUPER enables staking, protocol buybacks, and sustainable yield while supporting a growing suite of decentralized applications.

SuperFarm

SuperFarm ($SUPER) is capturing significant attention due to its recent breakout and an Upbit listing announcement, fueling widespread community discussion. Crypto influencers are actively touting its potential, with investors debating future price targets and its role within the burgeoning GameFi and Web3 gaming sectors.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is actively trending after announcing compelling Phase 1 clinical trial results for its soquelitinib drug, generating significant excitement around its potential for treating atopic dermatitis and other immune-mediated diseases. Community discussion highlights both the drug's promising safety and efficacy, fueling bullish sentiment and short squeeze speculation, alongside ongoing concerns about potential dilution from a proposed public offering.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending due to strong speculation about an upcoming IPO for its AI chip unit, T-Head, coupled with its deepening integration of AI across core services like Taobao with its Qwen app. The community is largely bullish on these AI initiatives, anticipating a significant rally and a re-rating of Chinese tech names. This narrative positions Alibaba as a key player in China's burgeoning AI growth story, though some market participants remain cautious of broader geopolitical and economic headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


eviltotoio

eviltotoio